From Nasdaq: 2024-05-14 16:00:02

Dynatrace, Inc. (DT) is set to report Q1 earnings with an estimated EPS of $0.14, a 30% decrease from last year. Zacks predicts a 2024 P/E ratio of 74.06, showing potential growth. monday.com Ltd. (MNDY) projects an EPS of $-0.11, a 65.63% increase from the same quarter in 2023. Zacks reports a 2024 P/E ratio of -1133.00. MakeMyTrip Limited (MMYT) expects an EPS of $0.19, up 35.71% from last year, and Zacks predicts a P/E ratio of 87.91. Sportradar Group AG (SRAD) forecasts EPS of $0.04 for a 33.33% increase year-over-year, with a 2024 P/E ratio of 31.40. Dole plc (DOLE) anticipates an EPS of $0.31, an 8.82% decrease from last year. Zacks expects a P/E ratio of 10.44 for the company. Perspective Therapeutics, Inc. (CATX) is projected to report an EPS of $-0.03, after reporting $0 EPS in the same quarter last year. Nayax Ltd. (NYAX) has an estimated EPS of $-0.02, showing an 88.24% increase from Q1 2023. Zacks predicts a P/E ratio of 364.38 for NYAX. Hut 8 Corp. (HUT) is expected to report an EPS of $-0.06, an 86.67% increase from last year, with a 2024 P/E ratio of -6.67 according to Zacks. Riskified Ltd. (RSKD) looks to report an EPS of $-0.06, a 33.33% increase from last year, with a 2024 P/E ratio of -28.33. European Wax Center, Inc. (EWCZ) estimates an EPS of $0.04, a 300% increase from the same quarter in 2023. Zacks predicts a P/E ratio of 37.10. Bitfarms Ltd. (BITF) anticipates an EPS of $-0.03, a 200% decrease from last year, with a Zacks-reported 2024 P/E ratio of -17.67. Adaptimmune Therapeutics plc (ADAP) forecasts an EPS of $-0.16, a 1700% decrease from Q1 2023, with a predicted 2024 P/E ratio of -2.39 according to Zacks.



Read more at Nasdaq:: Pre-Market Earnings Report for May 15, 2024 : DT, MNDY, MMYT, SRAD, DOLE, CATX, NYAX, HUT, RSKD, EWCZ, BITF, ADAP